T. Rowe Price Associates’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-61,200
| Closed | -$5K | – | 3007 |
|
|
2022
Q4 | $5K | Hold |
61,200
| – | – | ﹤0.01% | 2916 |
|
|
2022
Q3 | $8K | Hold |
61,200
| – | – | ﹤0.01% | 2934 |
|
|
2022
Q2 | $17K | Buy |
61,200
+49,500
| +423% | +$13.8K | ﹤0.01% | 2930 |
|
|
2022
Q1 | $4K | Buy |
+11,700
| New | +$4K | ﹤0.01% | 2964 |
|
|
2021
Q1 | – | Sell |
-17,000
| Closed | -$59K | – | 2879 |
|
|
2020
Q4 | $59K | Buy |
+17,000
| New | +$59K | ﹤0.01% | 2643 |
|